557 related articles for article (PubMed ID: 27830716)
1. Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease.
Sato E; Mori T; Mishima E; Suzuki A; Sugawara S; Kurasawa N; Saigusa D; Miura D; Morikawa-Ichinose T; Saito R; Oba-Yabana I; Oe Y; Kisu K; Naganuma E; Koizumi K; Mokudai T; Niwano Y; Kudo T; Suzuki C; Takahashi N; Sato H; Abe T; Niwa T; Ito S
Sci Rep; 2016 Nov; 6():36618. PubMed ID: 27830716
[TBL] [Abstract][Full Text] [Related]
2. Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction.
Enoki Y; Watanabe H; Arake R; Fujimura R; Ishiodori K; Imafuku T; Nishida K; Sugimoto R; Nagao S; Miyamura S; Ishima Y; Tanaka M; Matsushita K; Komaba H; Fukagawa M; Otagiri M; Maruyama T
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):735-747. PubMed ID: 28608457
[TBL] [Abstract][Full Text] [Related]
3. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
[TBL] [Abstract][Full Text] [Related]
4. Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1.
Enoki Y; Watanabe H; Arake R; Sugimoto R; Imafuku T; Tominaga Y; Ishima Y; Kotani S; Nakajima M; Tanaka M; Matsushita K; Fukagawa M; Otagiri M; Maruyama T
Sci Rep; 2016 Aug; 6():32084. PubMed ID: 27549031
[TBL] [Abstract][Full Text] [Related]
5. The double-edged sword of endoplasmic reticulum stress in uremic sarcopenia through myogenesis perturbation.
Jheng JR; Chen YS; Ao UI; Chan DC; Huang JW; Hung KY; Tarng DC; Chiang CK
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):570-584. PubMed ID: 29380555
[TBL] [Abstract][Full Text] [Related]
6. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions.
Watanabe H; Enoki Y; Maruyama T
Biol Pharm Bull; 2019; 42(9):1437-1445. PubMed ID: 31474705
[TBL] [Abstract][Full Text] [Related]
8. Uremic toxicity of indoxyl sulfate.
Niwa T
Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
[TBL] [Abstract][Full Text] [Related]
9. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
Liu WC; Tomino Y; Lu KC
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
[TBL] [Abstract][Full Text] [Related]
10. Indoxyl Sulfate Might Play a Role in Sarcopenia, While Myostatin Is an Indicator of Muscle Mass in Patients with Chronic Kidney Disease: Analysis from the RECOVERY Study.
Lee SM; Han MY; Kim SH; Cha RH; Kang SH; Kim JC; An WS
Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287929
[TBL] [Abstract][Full Text] [Related]
11. Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB.
Bolati D; Shimizu H; Yisireyili M; Nishijima F; Niwa T
BMC Nephrol; 2013 Mar; 14():56. PubMed ID: 23496811
[TBL] [Abstract][Full Text] [Related]
12. Indoxyl Sulfate, a Uremic Endotheliotoxin.
Lano G; Burtey S; Sallée M
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260489
[TBL] [Abstract][Full Text] [Related]
13. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
Niwa T
Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
[TBL] [Abstract][Full Text] [Related]
14. AST-120 ameliorates lowered exercise capacity and mitochondrial biogenesis in the skeletal muscle from mice with chronic kidney disease via reducing oxidative stress.
Nishikawa M; Ishimori N; Takada S; Saito A; Kadoguchi T; Furihata T; Fukushima A; Matsushima S; Yokota T; Kinugawa S; Tsutsui H
Nephrol Dial Transplant; 2015 Jun; 30(6):934-42. PubMed ID: 25878055
[TBL] [Abstract][Full Text] [Related]
15. The uremic toxin indoxyl sulfate exacerbates reactive oxygen species production and inflammation in 3T3-L1 adipose cells.
Stockler-Pinto MB; Saldanha JF; Yi D; Mafra D; Fouque D; Soulage CO
Free Radic Res; 2016; 50(3):337-44. PubMed ID: 26617268
[TBL] [Abstract][Full Text] [Related]
16. P
Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
[TBL] [Abstract][Full Text] [Related]
17. Skeletal Muscle Injury in Chronic Kidney Disease-From Histologic Changes to Molecular Mechanisms and to Novel Therapies.
Heitman K; Alexander MS; Faul C
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791164
[TBL] [Abstract][Full Text] [Related]
18. Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access.
Wu CC; Hung SC; Kuo KL; Tarng DC
Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28067862
[TBL] [Abstract][Full Text] [Related]
19. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.
Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G
J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975
[TBL] [Abstract][Full Text] [Related]
20. Indoxyl sulfate is a nephro-vascular toxin.
Niwa T
J Ren Nutr; 2010 Sep; 20(5 Suppl):S2-6. PubMed ID: 20797565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
